JANELLE ASHMORE: Open Payments
NPI 1710604418 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,761 in 68 payments from 30 companies in 2025. Trend: 2023 $2,469 · 2024 $5,836 · 2025 $1,761
Food & beverage: $1,661Education: $100
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 21 | $422 |
| Eisai Inc. | 3 | $182 |
| Merck Sharp & Dohme LLC | 5 | $131 |
| SEAGEN INC. | 1 | $100 |
| AstraZeneca Pharmaceuticals LP | 4 | $98 |
| Janssen Biotech, Inc. | 3 | $70 |
| SOBI, INC | 2 | $60 |
| GlaxoSmithKline, LLC. | 2 | $59 |
| PFIZER INC. | 2 | $58 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $47 |
Products named: Enhertu, Lenvima, DATROWAY, KEYTRUDA, LYNPARZA, Vonjo, Nubeqa, PRECISETUMOR.
Industry payments across TX — which companies pay providers there.
